MRCT – A process to make a treatment or vaccine available during a public health emergency, before all research is complete, and before full approval is granted.
https://mrctcenter.org/glossaryterm/emergency-use-authorization-eua/
CDISC-Gloss – Approval by FDA for the emergency use of certain unapproved medical products or an unapproved use of an approved medical product for certain emergency circumstances, when applied for under a declared health emergency. These medical products may be referred to as medical countermeasures (MCMs) and may include drugs, biologics, and devices. [After Emergency Use Authorization of Medical Products and Related Authorities. FDA Guidance for Industry and Other Stakeholders. January 2017.] See also pre-approval access.